Ryan Weispfenning | Vice President & Head of Investor Relations |
Geoffrey Martha | Chairman & Chief Executive Officer |
Karen Parkhill | Chief Financial Officer |
Sean Salmon | EVP & President of the Cardiovascular and Diabetes Operating Unit |
Bob White | EVP & President of Medical Surgical Portfolio |
Brett Wall | EVP & President of Neuroscience Portfolio |
Robbie Marcus | JPMorgan |
Vijay Kumar | Evercore ISI |
Larry Biegelsen | Wells Fargo |
Matthew Taylor | UBS |
Cecilia Furlong | Morgan Stanley |
Matthew Miksic | Credit Suisse |
Joanne Wuensch | Citigroup |
Matthew O'Brien | Piper Sandler |
Chris Pasquale | Guggenheim Securities |
Frederick Wise | Stifel |
Good morning, and welcome to Medtronic's Fiscal Year 2022 Second Quarter Earnings Video Webcast. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations.
Before we start the prepared remarks, I'll share a few details about today's webcast.
Joining me are Geoff Martha, Medtronic Chairman and Chief Executive Officer; and Karen Parkhill, Medtronic Chief Financial Officer. Geoff and Karen will provide comments on the results of our second quarter, which ended on October 29, 2021, and our outlook for the remainder of the fiscal year.